Material Agreement Form 8 K

Item 1.01 Entry into a Material Definitive Agreement.

On December 11, 2024, the Board of Directors (the "Board") of Akoya Biosciences, Inc. (the "Company") approved an updated form indemnification agreement (the "Agreement") for its non-employee directors and executive officers. Amendments to the form indemnification agreement include: (1) an expanded definition of indemnifiable expenses; (2) a requirement that the Company purchase a six-year directors and officers ("D&O") insurance tail in the event of a Change in Control (as defined in the Agreement) of the Company; (3) a requirement that the Company pursue D&O insurance coverage for indemnitees; (4) additional provisions concerning independent counsel indemnification determination rights; and (5) clarifying amendments to the clawback indemnification preclusion provision. The Company intends to enter into the Agreement with each of its current and future non-employee directors and executive officers.

The foregoing description of the indemnification agreement is qualified in its entirety by reference to the form attached as Exhibit 10.1.